These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 19435712)

  • 1. Plasma protein pentosidine and carboxymethyllysine, biomarkers for age-related macular degeneration.
    Ni J; Yuan X; Gu J; Yue X; Gu X; Nagaraj RH; Crabb JW;
    Mol Cell Proteomics; 2009 Aug; 8(8):1921-33. PubMed ID: 19435712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration.
    Gu X; Meer SG; Miyagi M; Rayborn ME; Hollyfield JG; Crabb JW; Salomon RG
    J Biol Chem; 2003 Oct; 278(43):42027-35. PubMed ID: 12923198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing susceptibility to age-related macular degeneration with proteomic and genomic biomarkers.
    Gu J; Pauer GJ; Yue X; Narendra U; Sturgill GM; Bena J; Gu X; Peachey NS; Salomon RG; Hagstrom SA; Crabb JW;
    Mol Cell Proteomics; 2009 Jun; 8(6):1338-49. PubMed ID: 19202148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic and genomic biomarkers for age-related macular degeneration.
    Gu J; Pauer GJ; Yue X; Narendra U; Sturgill GM; Bena J; Gu X; Peachey NS; Salomon RG; Hagstrom SA; Crabb JW;
    Adv Exp Med Biol; 2010; 664():411-7. PubMed ID: 20238042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentosidine and N-carboxymethyl-lysine: biomarkers for type 2 diabetic retinopathy.
    Ghanem AA; Elewa A; Arafa LF
    Eur J Ophthalmol; 2011; 21(1):48-54. PubMed ID: 20544678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum carboxymethyllysine, an advanced glycation end product, and age-related macular degeneration: the Age, Gene/Environment Susceptibility-Reykjavik Study.
    Semba RD; Cotch MF; Gudnason V; Eiríksdottir G; Harris TB; Sun K; Klein R; Jonasson F; Ferrucci L; Schaumberg DA
    JAMA Ophthalmol; 2014 Apr; 132(4):464-70. PubMed ID: 24481410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Levels of Pentosidine, Carboxymethyl-Lysine, Soluble Receptor for Advanced Glycation End Products, and Metabolic Syndrome: The Metformin Effect.
    Haddad M; Knani I; Bouzidi H; Berriche O; Hammami M; Kerkeni M
    Dis Markers; 2016; 2016():6248264. PubMed ID: 27829696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Application of Mass Spectroscopy Assays for Nε-(1-Carboxymethyl)-L-Lysine and Pentosidine in Renal Failure and Diabetes.
    O'Grady KL; Khosla S; Farr JN; Bondar OP; Atkinson EJ; Achenbach SJ; Eckhardt BA; Thicke BS; Tweed AJ; Volkman TL; Drake MT; Hines JM; Singh RJ
    J Appl Lab Med; 2020 May; 5(3):558-568. PubMed ID: 32445362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CEP biomarkers as potential tools for monitoring therapeutics.
    Renganathan K; Gu J; Rayborn ME; Crabb JS; Salomon RG; Collier RJ; Kapin MA; Romano C; Hollyfield JG; Crabb JW
    PLoS One; 2013; 8(10):e76325. PubMed ID: 24098476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased serum concentrations of pentosidine are related to presence and severity of coronary artery disease.
    Kerkeni M; Weiss IS; Jaisson S; Dandana A; Addad F; Gillery P; Hammami M
    Thromb Res; 2014 Sep; 134(3):633-8. PubMed ID: 25065554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia?
    Miyata T; Fu MX; Kurokawa K; van Ypersele de Strihou C; Thorpe SR; Baynes JW
    Kidney Int; 1998 Oct; 54(4):1290-5. PubMed ID: 9767546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in the advanced glycation end product pentosidine in Bruch's membrane with age.
    Handa JT; Verzijl N; Matsunaga H; Aotaki-Keen A; Lutty GA; te Koppele JM; Miyata T; Hjelmeland LM
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):775-9. PubMed ID: 10067983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of advanced glycation end-products and their receptor on outcome in heart failure patients with preserved and reduced ejection fraction.
    Willemsen S; Hartog JW; van Veldhuisen DJ; van der Meer P; Roze JF; Jaarsma T; Schalkwijk C; van der Horst IC; Hillege HL; Voors AA
    Am Heart J; 2012 Nov; 164(5):742-749.e3. PubMed ID: 23137505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced glycation end-products pentosidine and N epsilon-carboxymethyllysine are elevated in serum of patients with osteoporosis.
    Hein G; Wiegand R; Lehmann G; Stein G; Franke S
    Rheumatology (Oxford); 2003 Oct; 42(10):1242-6. PubMed ID: 12777635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of the advanced glycation end products Nepsilon-carboxymethyllysine and pentosidine are not influenced by treatment with the angiotensin receptor II type 1 blocker irbesartan in patients with type 2 diabetic nephropathy and hypertension.
    Busch M; Franke S; Wolf G; Rohde RD; Stein G;
    Nephron Clin Pract; 2008; 108(4):c291-7. PubMed ID: 18434751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure.
    Miyata T; Wada Y; Cai Z; Iida Y; Horie K; Yasuda Y; Maeda K; Kurokawa K; van Ypersele de Strihou C
    Kidney Int; 1997 Apr; 51(4):1170-81. PubMed ID: 9083283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes.
    Miura J; Yamagishi Si; Uchigata Y; Takeuchi M; Yamamoto H; Makita Z; Iwamoto Y
    J Diabetes Complications; 2003; 17(1):16-21. PubMed ID: 12505751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of pentosidine in diabetic patients: an advanced glycation end product.
    Sugiyama S; Miyata T; Ueda Y; Tanaka H; Maeda K; Kawashima S; Van Ypersele de Strihou C; Kurokawa K
    J Am Soc Nephrol; 1998 Sep; 9(9):1681-8. PubMed ID: 9727377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carboxyethylpyrrole oxidative protein modifications stimulate neovascularization: Implications for age-related macular degeneration.
    Ebrahem Q; Renganathan K; Sears J; Vasanji A; Gu X; Lu L; Salomon RG; Crabb JW; Anand-Apte B
    Proc Natl Acad Sci U S A; 2006 Sep; 103(36):13480-4. PubMed ID: 16938854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of advanced glycation end products in human cataractous lenses.
    Franke S; Dawczynski J; Strobel J; Niwa T; Stahl P; Stein G
    J Cataract Refract Surg; 2003 May; 29(5):998-1004. PubMed ID: 12781289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.